Back to ACAD
STATE STREET CORP ACAD Position History
Acadia Pharmaceuticals Inc. • Healthcare
Quarters held
12
Latest value
$229.6M
Q2 2026
Peak value
$229.6M
First seen
Q4 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2023 | $202.4M |
| Q1 2024 | $111M |
| Q2 2024 | $94.3M |
| Q3 2024 | $91.9M |
| Q4 2024 | $83M |
| Q1 2025 | $116.2M |
| Q2 2025 | $133.3M |
| Q3 2025 | $154.8M |
| Q4 2025 | $211.3M |
| Q1 2026 | $185.5M |
| Q2 2026 | $229.6M |
| Q2 2026 | $229.6M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $229.6M | 9.08M | — | — |
| Q2 2026 | $229.6M | 9.08M | — | — |
| Q1 2026 | $185.5M | 8.33M | — | — |
| Q4 2025 | $211.3M | 7.91M | — | — |
| Q3 2025 | $154.8M | 7.26M | — | — |
| Q2 2025 | $133.3M | 6.18M | — | — |
| Q1 2025 | $116.2M | 6.99M | — | — |
| Q4 2024 | $83M | 4.52M | — | — |
| Q3 2024 | $91.9M | 5.97M | — | — |
| Q2 2024 | $94.3M | 5.80M | — | — |
| Q1 2024 | $111M | 6.00M | — | — |
| Q4 2023 | $202.4M | 6.47M | — | — |
Other funds holding ACAD
$377M
$322.9M
$302.7M
$247.8M
$116.3M
$115.7M